Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-25T17:14:56.796Z Has data issue: false hasContentIssue false

Night sedation in the admission wards of a psychiatric hospital

Published online by Cambridge University Press:  02 January 2018

Richard P. W. Fry*
Affiliation:
St George's Hospital Medical School, Cranmer Terrace, London, SW17
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Since their introduction in the 1960s, benzodiazepine drugs have been widely prescribed for anxiety states and insomnia. Despite the initial hopes for these drugs being non-addictive and not producing tolerance, recent work has shown that there is a well defined withdrawal syndrome (Hallstrom & Lader, 1981; Petursson & Lader, 1981; Tyrer et al, 1981; Tyrer et al, 1983) and that tolerance has also been shown to occur (Aranko et al, 1983; Aranko et al, 1985). There has been widespread concern about these effects. The British National Formulary advocates that “used as hypnotics routine prescribing especially in hospitals is undesirable, and ideally they should be reserved for short courses of treatment in the acutely distressed” and that they should be discontinued as soon as possible. Indeed the Royal College of Psychiatrists' statement on benzodiazepine prescribing and the Committee on Safety of Medicines have recommended that their use as hypnotics should be considered only when the condition is severe, disabling or subjecting the individual to extreme distress. Tyrer & Murphy (1987) have recommended that these drugs are best used for no longer than two weeks in regular dosage.

Type
Articles
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1989

References

Aranko, K., Mattilsa, M. & Seppala, T. (1983) Development of tolerance and cross tolerance to the psychomotor actions of lorazepan and diazepam in man. British Journal of Clinical Pharmacology, 15, 545552.CrossRefGoogle Scholar
Aranko, K., Mattilsa, M., Nuutilla, A. & Pellinen, J. (1985) Benzodiazepines, but not antidepressants or neuroleptics, induce dose-dependent development of tolerance to lorazepam in psychiatric patients. Acta Psychiatrica Scandinavica, 72, 436446.CrossRefGoogle ScholarPubMed
British National Formulary, 15, (1988) p. 136. Londor: British Medical Association and The Pharmaceutical Society.Google Scholar
Hallstrom, C. & Lader, M. H. (1981) Benzodiazepine withdrawal phenomena. International Pharmacopsychiatry, 16, 235244.CrossRefGoogle ScholarPubMed
Petursson, H. & Lader, M. H. (1981) Withdrawal from long-term benzodiazepine treatment. British Medical Journal, 283, 643645.CrossRefGoogle ScholarPubMed
Royal College of Psychiatrists (1988) Benzodiazepines and dependence: a College Statement. Bulletin of the Royal College of Psychiatrists, 12, 107108.Google Scholar
Tyrer, P. & Murphy, S. (1987) The place of benzodiazepines in psychiatric practice. British Journal of Psychiatry, 151, 719723.CrossRefGoogle ScholarPubMed
Tyrer, P., Owen, R. & Dawling, S. (1983) Gradual withdrawal of diazepam after long therapy. Lancet, i, 14031406.Google Scholar
Tyrer, P., Rutherford, D. & Huggett, T. (1981) Benzodiazepine withdrawal symptoms and propranolol. Lancet, i, 520522.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.